A photo of Henry Akinbi.

Henry T. Akinbi, MD

  • Attending Neonatologist, Neonatology and Pulmonary Biology
  • Member, Perinatal Institute
  • Professor, UC Department of Pediatrics

About

Biography

As a neonatologist, my clinical specialty is neonatology with specific interests in neonatal infections and blood transfusions. My research areas include toxicology, pharmacometrics and microbiome.

My research is a natural extension of my clinical practice because it promotes evidence-based diagnoses and therapy. One of my goals is to understand the role of early antibiotic exposure on the overall health of neonates. My research aims to increase our understanding and rationale for managing neonatal abstinence syndrome.

One of my accomplishments is the provision of a webinar for the College of Clinical Pharmacologists. My work has been published in several well-respected journals, including the Journal of Clinical Pharmacology, BMJ Open Quality, Scientific Reports, Journal of Parenteral and Enteral Nutrition, Pediatrics, Journal of Pediatrics and Journal of Immunology.

I have been with Cincinnati Children’s for more than 26 years. Collaborations with clinicians and non-clinicians are welcome.

MD: University of Ife, Ile-Ife, Nigera, Africa, 1980.

Residency: Pediatrics, University of North Carolina at Chapel Hill, 1988-1991.

Neonatology Fellowship: Children's Hospital of Philadelphia, Philadelphia, PA, 1991-1994.

Certification: General Pediatrics, 1991; Recertification, 1998; Newborn Medicine, 1995; Recertification, 2002.

Interests

Neonatal infections; blood transfusions

Services and Specialties

Neonatology, Perinatal

Interests

Pharmacokinetis/pharmacodynamics of psychotropic medications in neonates; role of lysozyme in airway host defense

Research Areas

Neonatology, Pulmonary Biology, Developmental Biology

Additional Languages

French

Publications

Selected

Suggestions for Model-Informed Precision Dosing to Optimize Neonatal Drug Therapy. Euteneuer, JC; Kamatkar, S; Fukuda, T; Vinks, AA; Akinbi, HT. Journal of Clinical Pharmacology. 2019; 59:168-176.

Antibiotic exposure prevents acquisition of beneficial metabolic functions in the preterm infant gut microbiome. Xu, Y; Milburn, O; Beiersdorfer, T; Du, L; Akinbi, H; Haslam, DB. Microbiome. 2022; 10.

Identifying the essential knowledge and skills for Neonatal-Perinatal Medicine: a systematic analysis of practice. Hubbard, DK; Wambach, JA; LaTuga, MS; Dwyer, A; Aurora, S; Lorch, SA; Akinbi, HT. Journal of Perinatology. 2022; 42:1266-1270.

Epidemiological Investigation on the Current Practice of Umbilical Cord Clamping in China. Zhu, J; Xie, Y; Wang, B; Wang, Y; Akinbi, H; Xie, L. American Journal of Perinatology. 2022; 39:1015-1019.

A review of pregnancy-induced changes in opioid pharmacokinetics, placental transfer, and fetal exposure: Towards fetomaternal physiologically-based pharmacokinetic modeling to improve the treatment of neonatal opioid withdrawal syndrome. van Hoogdalem, MW; Wexelblatt, SL; Akinbi, HT; Vinks, AA; Mizuno, T. Pharmacology and Therapeutics. 2022; 234.

Utility of Repeat Testing for Congenital Hypothyroidism in Infants with Very Low Birth Weight. Rose, SR; Blunden, CE; Jarrett, OO; Kaplan, K; Caravantes, R; Akinbi, HT. Journal of Pediatrics. 2022; 242:152-158.e1.

Physiologically-Based Pharmacokinetic Modeling to Investigate the Effect of Maturation on Buprenorphine Pharmacokinetics in Newborns with Neonatal Opioid Withdrawal Syndrome. van Hoogdalem, MW; Johnson, TN; McPhail, BT; Kamatkar, S; Wexelblatt, SL; Ward, LP; Christians, U; Akinbi, HT; Vinks, AA; Mizuno, T. Clinical Pharmacology and Therapeutics. 2022; 111:496-508.

Opioid Treatment for Neonatal Opioid Withdrawal Syndrome: Current Challenges and Future Approaches. McPhail, BT; Emoto, C; Butler, D; Fukuda, T; Akinbi, H; Vinks, AA. Journal of Clinical Pharmacology. 2021; 61:857-870.

Impact of Institutional Breastfeeding Support in Very Low-Birth Weight Infants. Ward, LP; Tonnis, R; Otuneye, AT; Clemens, N; Akinbi, H; Morrow, AL. Breastfeeding Medicine. 2021; 16:238-244.

Physiologic Indirect Response Modeling to Describe Buprenorphine Pharmacodynamics in Newborns Treated for Neonatal Opioid Withdrawal Syndrome. Mizuno, T; McPhail, BT; Kamatkar, S; Wexelblatt, S; Ward, L; Christians, U; Akinbi, HT; Vinks, AA. Clinical Pharmacokinetics. 2021; 60:249-259.

Patient Ratings and Comments

All patient satisfaction ratings and comments are submitted by actual patients and verified by a leading independent patient satisfaction company, NRC Health. Patient identities are withheld to ensure confidentiality and privacy. Only those providers whose satisfaction surveys are administered through Cincinnati Children’s Hospital Medical Center are displayed. Click here to learn more about our survey